Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VI-1121 in Alzheimer's Disease
NCT01428362Phase 2Completed
- Sponsor
- VIVUS
- Start
- Aug 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VI-1121 in Alzheimer's disease (AD), sponsored by VIVUS. Started Aug 2011; status: completed.
02
Drugs
VI-1121
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01428362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01428362.